Zain Khalpey: Recognizing High-Risk Coronary Hematoma Characteristics During PCI
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared a post on LinkedIn about a recent article by Takunori Tsukui et al., published in JACC: Cardiovascular Interventions, adding:
“This JACC study highlights several imaging features associated with worsening hematomas, including extramedial location, larger hematoma size, greater stent edge hinge motion, and hematomas extending into a normal artery segment without a side branch.
Notably, coronary hematoma was the second leading ischemic cause of emergent return to the catheterization laboratory, behind stent thrombosis, and half of these cases were associated with myocardial infarction.
As intravascular imaging becomes increasingly integrated into PCI, recognizing high risk hematoma characteristics may help guide management and improve outcomes.”
Title: Characteristics of Coronary Intra- or Extramedial Hematomas Causing Emergent Return to Catheterization Laboratory After Percutaneous Coronary Intervention
Authors: Takunori Tsukui, Ge Jin, Kei Yamamoto, Takehiko Kido, Mitsuaki Matsumura, Yu-Wei Chen, Yoichiro Sugizaki, Khady N. Fall, Cameron Balish, Kartik Kodali, Maria Munoz Cifuentes, Mary K. Egan, Megha Prasad, Vivian Ng, Sanjum S. Sethi, Tamim M. Nazif, Sahil A. Parikh, Torsten P. Vahl, LeRoy E. Rabbani, Michael B. Collins, Martin B. Leon, Jeffrey W. Moses, Margaret McEntegart, Ajay J. Kirtane, Gary S. Mintz, Akiko Maehara

Other posts featuring Zain Khalpey on Hemostasis Today.
-
Jul 13, 2026, 14:42Bruno Pougault: The Global Momentum Behind Innovation in Thrombosis and Hemostasis
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026